1-12 of 12
Jeffrey Skinner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 Study of Dasatinib with and without Venetoclax in Patients with Early Chronic Phase Chronic Myeloid Leukemia (ECP-CML)

Fadi G. Haddad, Elias Jabbour, Koji Sasaki, Lewis Nasr, Xuelin Huang, Ghayas C. Issa, Farhad Ravandi, Guillermo Garcia-Manero, Tapan M. Kadia, Naval Daver, Yesid Alvarado Valero, Cedric Nasnas, Maro Ohanian, Nicholas J. Short, Lucia Masarova, Marianne Zoghbi, Patrice Eric Nasnas, Guillermo Montalban-Bravo, Jeffrey Skinner, Sherry Pierce, Michael Andreeff, Hagop M. Kantarjian
Journal: Blood
Blood (2023) 142 (Supplement 1): 870.
https://doi.org/10.1182/blood-2023-188236
Published: 2023
Journal Articles

Outcome of Third-Line Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia in Chronic Phase: A Propensity Score Analysis

Elias Jabbour, Koji Sasaki, Ghayas C. Issa, Fadi Haddad, Guillermo Garcia-Manero, Tapan M. Kadia, William G. Wierda, Musa Yilmaz, Courtney D. DiNardo, Jeffrey Skinner, Naveen Pemmaraju, Sara E Dellasala, Sherry A. Pierce, Jorge E. Cortes, Hagop Kantarjian
Journal: Blood
Blood (2022) 140 (Supplement 1): 809–811.
https://doi.org/10.1182/blood-2022-169772
Published: 2022
Journal Articles

More Than Ten Years Follow-up of Frontline Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myeloid Leukemia

Fadi Haddad, Koji Sasaki, Ghayas C. Issa, Kunhwa Kim, Jeffrey Skinner, Sara E Dellasala, Yesid Alvarado, Alessandra Ferrajoli, Tapan M. Kadia, Musa Yilmaz, Naveen Pemmaraju, Guillermo Garcia-Manero, Sherry A. Pierce, Elias Jabbour, Hagop Kantarjian
Journal: Blood
Blood (2022) 140 (Supplement 1): 3897–3899.
https://doi.org/10.1182/blood-2022-168604
Published: 2022
Journal Articles

Prognostic Model of Transformation to Blast Phase in Patients with Chronic Myeloid Leukemia

Alex Bataller, Koji Sasaki, Elias Jabbour, Ghayas C. Issa, Fadi Haddad, Jeffrey Skinner, Sara E Dellasala, Guillermo Garcia-Manero, Sherry A. Pierce, Hagop Kantarjian
Journal: Blood
Blood (2022) 140 (Supplement 1): 3895–3896.
https://doi.org/10.1182/blood-2022-164924
Published: 2022
Journal Articles

Long-Term Follow-up of Low-Dose Dasatinib (50mg Daily) As Frontline Therapy in Newly Diagnosed Chronic Myeloid Leukemia

Georgina Gener-Ricos, Fadi Haddad, Koji Sasaki, Ghayas C. Issa, Jeffrey Skinner, Koichi Takahashi, Lucia Masarova, Jan A. Burger, Gautam Borthakur, Prithviraj Bose, Guillermo Garcia-Manero, Elias Jabbour, Hagop Kantarjian
Journal: Blood
Blood (2022) 140 (Supplement 1): 1493–1494.
https://doi.org/10.1182/blood-2022-167764
Published: 2022
Journal Articles

Low-Dose Dasatinib 50 Mg/Day Versus Standard-Dose Dasatinib 100 Mg/Day As Frontline Therapy in Chronic Myeloid Leukemia in Chronic Phase: A Propensity Score Analysis

Koji Sasaki, Elias J. Jabbour, Ghayas C. Issa, Kiran Naqvi, Jeffrey Skinner, Kristin Anderson, Sara E Dellasala, Musa Yilmaz, Alessandra Ferrajoli, Prithviraj Bose, Philip A. Thompson, Yesid Alvarado, Nitin Jain, Guillermo Garcia-Manero, Koichi Takahashi, Jan A. Burger, Gautam Borthakur, Naveen Pemmaraju, Fadi Haddad, Maria R Khouri, Shilpa Paul, Sherry A. Pierce, Jorge E. Cortes, Hagop Kantarjian
Journal: Blood
Blood (2021) 138 (Supplement 1): 631.
https://doi.org/10.1182/blood-2021-152614
Published: 2021
Journal Articles

Impact of Molecular Response at Specific Timepoints in Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Second Generation Tyrosine Kinase Inhibitors

Koji Sasaki, MD, Hagop M. Kantarjian, MD, Ghayas C. Issa, MD, Guillermo Garcia-Manero, MD, Tapan M. Kadia, MD, William G. Wierda, MD PhD, Musa Yilmaz, MD, Courtney D. DiNardo, MD MSCE, Jeffrey Skinner, MHA, Rita Khouri, Naveen Pemmaraju, MD, Patrice Nasnas, MD, Sara E Dellasala, BS, Sherry A. Pierce, BSN, BA, Jorge E. Cortes, MD, Elias Jabbour, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–44.
https://doi.org/10.1182/blood-2020-143023
Published: 2020
Journal Articles

The Comparison of Frontline Lower-Dose Dasatinib 50 Mg/Day to Standard-Dose Dasatinib 100 Mg/Day in Newly Diagnosed Chronic Myeloid Leukemia: A Propensity Score Analysis

Koji Sasaki, MD, Elias Jabbour, MD, Kiran Naqvi, MD MPH, Jeffrey Skinner, MHA, Kristin Anderson, Sara E Dellasala, BS, Musa Yilmaz, MD, Alessandra Ferrajoli, MD, Prithviraj Bose, MD, Philip A. Thompson, MB, MS, Yesid Alvarado, MD, Nitin Jain, MD, Guillermo Garcia-Manero, MD, Koichi Takahashi, MD PhD, Jan A. Burger, MD PhD, Gautam Borthakur, MD, Naveen Pemmaraju, MD, Rita Khouri, Shilpa Paul, PharmD, Sherry A. Pierce, BSN, BA, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 3–5.
https://doi.org/10.1182/blood-2020-140003
Published: 2020
Journal Articles

Outcomes of Patients with Chronic Myeloid Leukemia Treated with Third-Line Tyrosine Kinase Inhibitors

Koji Sasaki, MD, Elias Jabbour, MD, Ghayas C. Issa, MD, Guillermo Garcia-Manero, MD, Tapan M. Kadia, MD, William G. Wierda, MD PhD, Musa Yilmaz, MD, Courtney D. DiNardo, MD MSCE, Jeffrey Skinner, MHA, Maria Khouri, Naveen Pemmaraju, MD, Patrice Nasnas, MD, Sherry A. Pierce, BSN, BA, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-142954
Published: 2020
Journal Articles

The Impact of Treatment Recommendation By Leukemia Artificial Intelligence Program (LEAP) on Survival in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Koji Sasaki, MD, Hagop M. Kantarjian, MD, Elias Jabbour, MD, Farhad Ravandi, MD, Marina Y Konopleva, MD PhD, Gautam M. Borthakur, MD, William G. Wierda, MD PhD, Naval G. Daver, MD, Koichi Takahashi, MD, Kiran Naqvi, MDMPH, Courtney D. DiNardo, MDMSc, Guillermo Montalban Bravo, MD, Rashmi Kanagal-Shamanna, MD, Naveen Pemmaraju, MD, Ghayas C. Issa, MD, Preetesh Jain, MBBS,MDDM,PhD, Jeffrey Skinner, MHA, Mary B. Rios, RN, Sherry A. Pierce, BSN, BA, Kelly Soltysiak, PhD, Junya Sato, Guillermo Garcia-Manero, MD, Jorge E. Cortes, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1642.
https://doi.org/10.1182/blood-2019-130148
Published: 2019
Journal Articles

Evaluating the Role of Lower Dose Dasatinib in Newly Diagnosed Early Chronic Phase-Chronic Myeloid Leukemia (CML-CP)

Kiran Naqvi, MDMPH, Jorge E. Cortes, MD, Jeffrey Skinner, MHA, Elias J. Jabbour, MD, Naveen Pemmaraju, MD, Prithviraj Bose, MD, Philip A Thompson, MBBS, Gautam Borthakur, MD, Zeev Estrov, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1611.
https://doi.org/10.1182/blood.V130.Suppl_1.1611.1611
Published: 2017
Journal Articles

Clinical Application of Artificial Intelligence in Patients with Chronic Myeloid Leukemia in Chronic Phase

Koji Sasaki, MD, Hagop M. Kantarjian, MD, Elias J. Jabbour, MD, Susan O'Brien, MD, Farhad Ravandi, MD, Marina Konopleva, MDPhD, Gautam Borthakur, MD, William G. Wierda, MD PhD, Naval Daver, MD, Koichi Takahashi, MD, Preetesh Jain, MBBS,MDDM,PhD, Jeffrey Skinner, Mary Beth Rios, RN, Sherry Pierce, BSN, BA, Guillermo Garcia-Manero, MD, Jorge E. Cortes, MD
Journal: Blood
Blood (2016) 128 (22): 940.
https://doi.org/10.1182/blood.V128.22.940.940
Published: 2016